Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
AMYLYX PHARMACEUTICALS INC
Ticker: AMLX
CUSIP: 03237H101
Class: Common Stock
Paradigm Biocapital Advisors LP's Holding History (CIK: 0001855655)
Note: Option positions (PUT/CALL) are excluded.
Q3 2025
Shares
1,900,000
Value ($000)
$25,821
Avg Close
$9.41
Range
$5.97 - $15.14
Period
Shares
Value ($000)
Average Close
Price Range
Q3 2025
1,900,000
$25,821
$9.41
$5.97 - $15.14